Kathmere Capital Management, LLC Johnson & Johnson Transaction History

Kathmere Capital Management, LLC

$917 Million
Q2 2024

A detailed history of Kathmere Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 15,284 shares of JNJ stock, worth $2.46 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

15,284

Previous 15,284 -0.0%

Holding current value

$2.46 Million

Previous $2.23 Million -0.0%

% of portfolio

0.24%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$144.38 - $157.78 $386,649 - $422,534	2,678 Added 21.24%	15,284 $2.23 Million
Q2 2024 Jul 01, 2024	SELL	$144.38 - $157.78 $391,414 - $427,741	-2,711 Reduced 17.7%	12,606 $1.84 Million
Q1 2024 Apr 16, 2024	BUY	$155.22 - $162.74 $420,801 - $441,188	2,711 Added 21.51%	15,317 $2.42 Million
Q4 2023 Apr 16, 2024	SELL	$145.6 - $158.88 $474,510 - $517,789	-3,259 Reduced 20.54%	12,606 $1.98 Million
Q3 2023 Oct 11, 2023	BUY	$155.75 - $174.48 $408,532 - $457,661	2,623 Added 19.81%	15,865 $2.47 Million
Q2 2023 Jul 11, 2023	BUY	$154.35 - $166.11 $30,098 - $32,391	195 Added 1.49%	13,242 $2.19 Million
Q1 2023 Apr 20, 2023	SELL	$151.05 - $180.26 $773,829 - $923,471	-5,123 Reduced 28.19%	13,047 $2.02 Million
Q4 2022 Jan 24, 2023	SELL	$160.2 - $179.79 $35,083 - $39,374	-219 Reduced 1.19%	18,170 $0
Q4 2022 Jan 24, 2023	BUY	$160.2 - $179.79 $1.34 Million - $1.51 Million	8,385 Added 83.82%	18,389 $0
Q3 2022 Oct 11, 2022	SELL	$161.33 - $179.52 $339,438 - $377,710	-2,104 Reduced 17.38%	10,004 $1.63 Million
Q2 2022 Aug 09, 2022	BUY	$168.19 - $186.01 $240,175 - $265,622	1,428 Added 13.37%	12,108 $2.15 Million
Q1 2022 Apr 28, 2022	BUY	$158.14 - $179.59 $900,449 - $1.02 Million	5,694 Added 114.2%	10,680 $1.89 Million
Q4 2021 Jan 27, 2022	SELL	$155.93 - $173.01 $198,966 - $220,760	-1,276 Reduced 20.38%	4,986 $853,000
Q3 2021 Oct 14, 2021	BUY	$161.5 - $179.47 $173,451 - $192,750	1,074 Added 20.7%	6,262 $1.01 Million
Q2 2021 Jul 29, 2021	BUY	$159.48 - $171.07 $102,705 - $110,169	644 Added 14.17%	5,188 $855,000
Q1 2021 May 07, 2021	BUY	$153.07 - $170.48 $48,676 - $54,212	318 Added 7.52%	4,544 $747,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $2,742 - $3,147	20 Added 0.48%	4,226 $665,000
Q3 2020 Nov 20, 2020	SELL	$140.38 - $153.83 $457,358 - $501,178	-3,258 Reduced 43.65%	4,206 $626,000
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $692,634 - $758,997	4,934 Added 195.02%	7,464 $1.1 Million
Q2 2020 Aug 05, 2020	SELL	$128.81 - $155.51 $172,476 - $208,227	-1,339 Reduced 34.61%	2,530 $356,000
Q1 2020 May 06, 2020	BUY	$111.14 - $153.99 $49,790 - $68,987	448 Added 13.1%	3,869 $507,000
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $436,177 - $500,971	3,421 New	3,421 $499,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $421B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.

Account

Kathmere Capital Management, LLC Johnson & Johnson Transaction History